October 30, 2019

News You Need - 3 Big Little Things from HealthXL - November 2019

Announcements/News
Chandana Fitzgerald
&

It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy new stories from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar. Interested in getting beyond the headlines? We’ve included three industry experts who can help you get behind these stories - just let us know if you’d like us to make the introduction!



1: Sandoz - Pear Therapeutics go their own separate ways

Story snapshot: Sandoz and Pear Therapeutics break up. Novartis' unit Sandoz teamed up in 2018 with Pear Therapeutics, one of the pioneers in launching a prescription digital therapeutic for substance use disorder, to potentially bring a new type of therapy to market. While Pear's reSET and reSET-O are FDA approved and have evidence of efficacy, perhaps that is not enough to enable Sandoz to help commercialize the solutions. Our recent report assesses the digital activities of the top 10 Pharma, and we have identified that Digital Therapeutics is the top area of partnership activity by big pharma. So, this announcement may shake things up a bit. 


Why is it notable? Pioneers may not always pave the way



Industry Implications - DTx enabling platforms, new business models


2: Amazon just acquired digital health technology company Health Navigator, and it will join the company's Amazon Care group.

Story snapshot: Amazon has acquired Health Navigator, a startup that develops APIs for online health services. Health Navigator will become part of Amazon Care, it’s pilot healthcare service program for employees (Pill Pack is part of this already). 


Why is it notable? It’s Amazon! 


Industry Implications - Nothing major just yet 


3: MC10, Inc. announces a collaboration with the University of Rochester to develop novel digital biomarkers for the Central Nervous System.

Story snapshot: Massachusetts company MC10 does biometric-sensor-enabled analytics and has been quite active in collecting biomarkers for neurological conditions. The collaboration will utilize the BioStamp nPoint system to collect continuous data allowing for the creation of algorithms to provide a quantitative assessment of disease progression, specifically for movement disorders.


Why is it notable? Fills a knowledge void in the objective assessment of movement disorders 

 

Industry Implications - Potential new treatments for debilitating neuromuscular diseases



What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.